Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | HPGD | P15428 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5377985 | 0.91 | — | — | |
| SCHEMBL5374696 | 0.84 | MEN1 (0.30) | KDM4ECYP2C19MEN1KMT2A | |
| SCHEMBL5369514 | 0.78 | LMNA (0.36) | ALDH1A1HTTLMNAMEN1MAPT | |
| SCHEMBL5382745 | 0.75 | NR1H3 (0.36) | ALDH1A1KDM4EHTTLMNATSHR | |
| SCHEMBL5374664 | 0.72 | PTGS1 (0.30) | — | |
| SCHEMBL5374686 | 0.71 | MPO (0.33) | MPOCYP2C19MEN1KMT2A | |
| SCHEMBL13259552 | 0.68 | POLB (0.35) | ALDH1A1HPGDKDM4EHTTLMNA | |
| SCHEMBL803151 | 0.66 | POLB (0.36) | — | |
| SCHEMBL5280188 | 0.65 | SLC9A1 (0.40) | ALDH1A1KDM4EHTTLMNATSHR | |
| SCHEMBL5370184 | 0.65 | KDM4E (0.34) | KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1541561-B1 | PYRAZOLE DERIVATIVES AND PROCESS FOR THE PRODUCTION THEREOF | IHARA CHEMICAL IND CO (JP) | 2014-07-23 | — | — | EP | disclosed |
| US-20070249844-A1 | Pyrazole derivatives and process for the production thereof | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
| US-7256298-B2 | Pyrazole derivatives and process for the production thereof | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-08-14 | — | — | US | disclosed |
| US-20050215797-A1 | Pyrazole derivatives and process for the production thereof | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2005-09-29 | — | — | US | disclosed |
| EP-1541561-A1 | PYRAZOLE DERIVATIVES AND PROCESS FOR THE PRODUCTION THEREOF | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2005-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249844-A1 | Pyrazole derivatives and process for the production thereof | CBR3, CYP4Z1, CYP4F3 | MPO 1778/4885ALDH1A1 373/4885HPGD 633/4885 |
| US-20050215797-A1 | Pyrazole derivatives and process for the production thereof | CBR3, CYP4Z1, CYP4F3 | MPO 1778/4885ALDH1A1 373/4885HPGD 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.